Name | BRM/BRG1 ATP Inhibitor-1 |
Synonyms | 1-(3-(DIFLUOROMETHYL)ISOTHIAZOL-5-YL)-3-(2-FLUORO-5-(HYDROXYMETHYL)PYRIDIN-4-YL)UREA 1-(3-(difluoromethyl)isothiazol-5-yl)-3-(2-fluoro-5-(hydroxymethyl)pyridin-4-yl)urea Urea, N-[3-(difluoromethyl)-5-isothiazolyl]-N'-[2-fluoro-5-(hydroxymethyl)-4-pyridinyl]- |
CAS | 2270879-17-7 |
Molecular Formula | C11H9F3N4O2S |
Molar Mass | 318.27 |
Density | 1.659±0.06 g/cm3(Predicted) |
Boling Point | 333.4±42.0 °C(Predicted) |
Solubility | Soluble in DMSO |
pKa | 11.76±0.70(Predicted) |
Storage Condition | -20℃ |
Use | BRM/BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM)/SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) and BRG1/SMARCA4 ATPase activity inhibitor (IC50s<0.005 µM). |
Target | BRM, BRG1 : ic50 ﹤0.005 µM |
Reference Show more | [1]. Papillon JPN, et al. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers. J Med Chem. 2018 Nov 21;61(22):10155-10172 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.142 ml | 15.71 ml | 31.42 ml |
5 mM | 0.628 ml | 3.142 ml | 6.284 ml |
10 mM | 0.314 ml | 1.571 ml | 3.142 ml |
5 mM | 0.063 ml | 0.314 ml | 0.628 ml |